Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Warrier

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 29, 1987
Glucose phosphate isomerase deficiency as a cause of hydrops fetalisY Ravindranath, D E Paglia, I Warrier, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1995
Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. Hemophilia Growth and Development StudyJ Jason, L A Sleeper, S M Donfield, et al.
Blood|February 1, 1997
Nephrotic syndrome as a complication of immune tolerance in hemophilia BB M Ewenstein, C Takemoto, I Warrier, et al.
American Journal of Hematology|May 1, 1994
Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study GroupJ Jason, J Murphy, L A Sleeper, et al.
Haemostasis|March 24, 1999
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use programS Arkin, H A Cooper, J J Hutter, et al.
Journal of Thrombosis and Haemostasis : JTH|May 28, 2008
Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patientsV S Blanchette, A D Shapiro, R J Liesner, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in haemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 29, 1987
Glucose phosphate isomerase deficiency as a cause of hydrops fetalisY Ravindranath, D E Paglia, I Warrier, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1995
Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. Hemophilia Growth and Development StudyJ Jason, L A Sleeper, S M Donfield, et al.
Blood|February 1, 1997
Nephrotic syndrome as a complication of immune tolerance in hemophilia BB M Ewenstein, C Takemoto, I Warrier, et al.
American Journal of Hematology|May 1, 1994
Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study GroupJ Jason, J Murphy, L A Sleeper, et al.
Haemostasis|March 24, 1999
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use programS Arkin, H A Cooper, J J Hutter, et al.
Journal of Thrombosis and Haemostasis : JTH|May 28, 2008
Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patientsV S Blanchette, A D Shapiro, R J Liesner, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in haemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Pageof 5